Ahmad Faizan, Sachdeva Punya, Sarkar Jasmine, Izhaar Raafiah
Department of Medical Elementology and Toxicology Jamia Hamdard University Delhi India.
Amity Institute of Neuropsychology and Neurosciences Amity University Noida Uttar Pradesh India.
Aging Med (Milton). 2022 Aug 15;6(1):71-81. doi: 10.1002/agm2.12221. eCollection 2023 Mar.
Alzheimer's disease (AD) is considered to be the most typical form of dementia that provokes irreversible cognitive impairment. Along with cognitive impairment, circadian rhythm dysfunction is a fundamental factor in aggravating AD. A link among circadian rhythms, sleep, and AD has been well-documented. The etiopathogenesis of circadian system disruptions and AD serves some general characteristics that also open up the possibility of viewing them as a mutually reliant path. In this review, we have focused on different factors that are related to circadian rhythm dysfunction. The various pathogenic factors, such as amyloid-beta, neurofibrillary tangles, oxidative stress, neuroinflammation, and circadian rhythm dysfunction may all contribute to AD. In this review, we also tried to focus on melatonin which is produced from the pineal gland and can be used to treat circadian dysfunction in AD. Aside from amyloid beta, tau pathology may have a notable influence on sleep. Conclusively, the center of this review is primarily based on the principal mechanistic complexities associated with circadian rhythm disruption, sleep deprivation, and AD, and it also emphasizes the potential therapeutic strategies to treat and prevent the progression of AD.
阿尔茨海默病(AD)被认为是引发不可逆认知障碍的最典型痴呆形式。除认知障碍外,昼夜节律功能障碍是加重AD的一个基本因素。昼夜节律、睡眠和AD之间的联系已有充分记录。昼夜节律系统紊乱与AD的发病机制具有一些共同特征,这也为将它们视为相互依存的路径提供了可能性。在这篇综述中,我们重点关注了与昼夜节律功能障碍相关的不同因素。各种致病因素,如β-淀粉样蛋白、神经原纤维缠结、氧化应激、神经炎症和昼夜节律功能障碍,都可能导致AD。在这篇综述中,我们还试图关注由松果体产生、可用于治疗AD昼夜节律功能障碍的褪黑素。除了β-淀粉样蛋白外,tau病理可能对睡眠有显著影响。总之,本综述主要围绕与昼夜节律紊乱、睡眠剥夺和AD相关的主要机制复杂性展开,同时也强调了治疗和预防AD进展的潜在治疗策略。
Aging Med (Milton). 2022-8-15
Ageing Res Rev. 2020-4-16
Alzheimers Res Ther. 2012-8-13
Recent Pat Endocr Metab Immune Drug Discov. 2011-5
Front Neuroendocrinol. 2019-5-15
CNS Neurol Disord Drug Targets. 2021
ACS Chem Neurosci. 2022-5-18
Curr Issues Mol Biol. 2025-7-15
Acta Pharm Sin B. 2025-6
NPJ Biol Timing Sleep. 2025
Front Neurosci. 2025-2-5
Front Psychiatry. 2021-5-7
JCI Insight. 2017-8-17
Mol Brain. 2017-8-1
Cold Spring Harb Perspect Biol. 2017-12-1